Enveric Biosciences
ENVB
ENVB
29 hedge funds and large institutions have $4.45M invested in Enveric Biosciences in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.01% → 0.02% (+0.01%)
4% less capital invested
Capital invested by funds: $4.64M → $4.45M (-$195K)
Holders
29
Holding in Top 10
–
Calls
$368K
Puts
$45K
Top Buyers
| 1 | +$690K | |
| 2 | +$372K | |
| 3 | +$365K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$246K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$246K |
Top Sellers
| 1 | -$32.1K | |
| 2 | -$27K | |
| 3 | -$26.8K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
Two Sigma Investments
New York
|
-$1.39K |